| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.57B | +6.7% |
| R&D Expense | $58.2M | -2.3% |
| SG&A Expense | $252.4M | -20.9% |
| Operating Income | -$19.0M | -15.4% |
| Pre-tax Income | -$15.7M | -17.0% |
| Income Tax | $1.1M | +124.0% |
| Net Income | -$21.3M | -137.0% |
| EPS (Basic) | -$0.14 | -133.3% |
| EPS (Diluted) | -$0.14 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $113.6M | -10.4% |
| Accounts Receivable | $87.7M | +2.0% |
| Current Assets | $268.0M | +0.6% |
| Total Assets | $390.7M | +1.3% |
| Current Liabilities | $185.9M | +31.2% |
| Total Liabilities | $185.9M | +31.2% |
| Stockholders' Equity | $204.9M | -15.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $191.5M | -8.4% |
| Capital Expenditures | $6.5M | +20.9% |
| Investing Cash Flow | -$19.5M | -44.2% |
| Financing Cash Flow | -$170.4M | +7.4% |
| Free Cash Flow | $185.0M | -9.2% |
| -133.3% |